News | December 15, 2022
China aims to lead next bio revolution in advanced biologics, says GlobalData
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The investment will enable the company to enter European markets as well as enhance margins in current markets
Sanjeev is currently the Country President for AstraZeneca Malaysia
EC grants conditional marketing authorization based on the EFFISAYIL trial
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Subscribe To Our Newsletter & Stay Updated
